Skip to content
naulon
Not checkedNot checked for notices yet.

The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up

Radouane El Ayachy, Radouane El Ayachy, Radouane El Ayachy and 14 more

Frontiers in Oncology · 2021

doi:10.3389/fonc.2021.603595 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

PurposeLung cancer represents the first cause of cancer-related death in the world. Radiomics studies arise rapidly in this late decade. The aim of this review is to identify important recent publications to be synthesized into a comprehensive review of the current status of radiomics in lung cancer at each step of the patients’ care.MethodsA literature review was conducted using PubMed/Medline for search of relevant peer-reviewed publications from January 2012 to June 2020ResultsWe identified several studies at each point of patient’s care: detection and classification of lung nodules (n=16), determination of histology and genomic (n=10) and finally treatment outcomes predictions (=23). We reported the methodology of those studies and their results and discuss the limitations and the progress to be made for clinical routine applications.ConclusionPromising perspectives arise from machine learning applications and radiomics based models in lung cancers, yet further data are necessary for their implementation in daily care. Multicentric collaboration and attention to quality and reproductivity of radiomics studies should be further consider.

Abstract licence: CC BY

References114

  1. 9.
  2. 13.
  3. 31.
  4. 32.
  5. 38.

35 more references, whose wording the paper’s licence keeps private.

All 114 references

Cited by papers we hold1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.